• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UnitedHealth Group Announces Leadership Transition

    5/13/25 6:30:00 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    • Stephen J. Hemsley named Chief Executive Officer
    • Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated
    • Company expects to return to growth in 2026

    UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley.

    "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company has ever faced," Hemsley said. "The Board and I have greatly valued his leadership and compassion as chief executive and as a director and wish him and his family the best.

    "UnitedHealth Group has tremendous opportunities to grow as we continue to help improve health care and to perform to our potential — and, in so doing, return to our long-term growth objective of 13 to 16 percent," Hemsley continued.

    "Leading the people of UnitedHealth Group has been a tremendous honor as they work every day to improve the health system, and they will continue to inspire me," Witty said.

    "Steve Hemsley brings a combination of strategic vision and deep operational focus that are highly valuable to our company," said Michele Hooper, lead independent director of UnitedHealth Group.

    Hemsley joined UnitedHealth Group as chief operating officer in 1997 and became president in 1999. He became Board chair in 2017.

    Additionally, the company suspended its 2025 outlook as care activity continued to accelerate while also broadening to more types of benefit offerings than seen in the first quarter, and the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected.

    The company expects to return to growth in 2026.

    Conference Call

    UnitedHealth Group will host a conference call with investors at 8:00 a.m. Eastern Time today, May 13. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company's website (www.unitedhealthgroup.com). Following the call, a webcast replay will be on the Investor Relations page through May 27, 2025. This release and the Form 8-K dated May 13, 2025, can also be accessed from the Investor Relations page of the company's website.

    About UnitedHealth Group

    UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.

    Forward-Looking Statements

    The statements, estimates, projections, guidance or outlook contained in this document include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities laws. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ's legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to complete, manage or integrate strategic transactions; risk and uncertainties associated with the sale of our remaining operations in South America; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events; failure to attract, develop, retain, and manage the succession of key employees and executives; our investment portfolio performance; impairment of our goodwill and intangible assets; failure to protect proprietary rights to our databases, software and related products; downgrades in our credit ratings; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, reinvest in our business, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock.

    This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250513712025/en/

    Investors: [email protected]

    Media: [email protected]

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00

      6/11/25 7:46:38 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00

      5/21/25 8:41:18 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by TD Cowen with a new price target

      TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00

      5/19/25 8:51:13 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    SEC Filings

    See more
    • SEC Form 8-K filed by UnitedHealth Group Incorporated

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/20/25 4:44:03 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/18/25 5:00:15 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form FWP filed by UnitedHealth Group Incorporated

      FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      6/17/25 5:23:28 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes

      AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is negative. The proceeds from UnitedHealth Group's recent $3 billion debt issuance are expected to be used for general corporate purposes, including repayment of short-term borrowings, commercial paper and/or upcoming debt maturities. As of May 31, 2025, UnitedHealth Group had approximately $12.7 billion of short-term borrowings outstanding. Financial leverage at the end of first quarter 2025 was e

      6/23/25 4:57:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota

      UnitedHealth Group (NYSE:UNH) today announced that it recently became aware of an unsolicited "mini-tender" offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group's common stock, representing significantly less than 1% of UnitedHealth Group's common stock outstanding. The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group's common stock exceeding $325.00 per share on the last full trading day before the offer expires. This means that unless this condition is waived by Tutanota, UnitedHealth Group shareholders who tender their shares in the offer will receive a below-market price. Tutano

      6/23/25 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie

      6/4/25 3:50:00 PM ET
      $UNH
      Medical Specialities
      Health Care